Literature DB >> 33007219

Lockdown impact on COVID-19 epidemics in regions across metropolitan France.

Simon Cauchemez1, Cécile Tran Kiem2, Juliette Paireau3, Patrick Rolland4, Arnaud Fontanet5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33007219      PMCID: PMC7524515          DOI: 10.1016/S0140-6736(20)32034-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Lockdowns have been used by most European countries in response to the COVID-19 pandemic. In France, a national lockdown was implemented on March 17, 2020. Some have questioned the need for a nationwide implementation given that most hospital admissions were concentrated in two of 13 regions; others have even questioned the impact of the lockdown on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread, arguing that the natural epidemic peak was about to be reached. Here we discuss the impact of lockdown on COVID-19 epidemics in regions across metropolitan France. On March 17, 2020, daily hospital admissions were indeed highest in Grand-Est (5·3 per 100 000 inhab­itants) and Île-de-France (3·6 per 100 000 inhabitants) regions. Yet a surge in COVID-19 hospital admissions was occurring at that time across all regions of metropolitan France, as depicted in the appendix. The COVID-19 epidemic spread from the eastern to the western parts of France, crossing the daily hospitalisation threshold of 1 per 100 000 inhabitants between March 10 (Grand-Est) and March 23, 2020 (Bretagne and Nouvelle-Aquitaine). Île-de-France (Paris region) experienced the highest rate of hos­pital admissions per day (10·0 per 100 000 inhabitants), and Bretagne the lowest (1·3 per 100 000 inhabitants). Regardless of the time the epidemic started in the region, and its scale, 12 of 13 regions experienced a peak in daily hospital admissions on average 11 days (range 8–14 days) after the lockdown was implemented. This figure corresponds to the mean duration between infection and hospital admission for the patients experiencing severe forms of disease. Since the different regions were at different stages of the pandemic at the time the lockdown was imple­mented, the synchrony in regional peaks strongly suggests that the lockdown, rather than the natural course of the epidemic, explains the peak in hospital admissions. Moreover, most regions were experiencing exponential growth in hospital admissions (appendix), such that saturation of local intensive care units might have occurred in those regions in the absence of any lockdown. Lockdown therefore appears to have been successful not only in alleviating the burden on the intensive care units of the two most severely affected regions of France, but also in preventing uncontrolled epidemics in other regions. These simple obser­vations support results from other studies which have estimated the impact of lockdown on SARS-CoV-2 spread to be strong.2, 3, 4, 5 Enforcement of public health and social measures in combination with important testing, tracing, and isolating capacities will be critical in case of an epidemic rebound to avoid re-introducing a lockdown—a situation for which the economic cost and broader impact on society are considerable.
  25 in total

1.  Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort-EPICOV.

Authors:  Josiane Warszawski; Laurence Meyer; Jeanna-Eve Franck; Delphine Rahib; Nathalie Lydié; Anne Gosselin; Emilie Counil; Robin Kreling; Sophie Novelli; Remy Slama; Philippe Raynaud; Guillaume Bagein; Vianney Costemalle; Patrick Sillard; Toscane Fourie; Xavier de Lamballerie; Nathalie Bajos
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

2.  The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273.

Authors:  Robert Markewitz; Daniela Pauli; Justina Dargvainiene; Katja Steinhagen; Sarah Engel; Victor Herbst; Dorinja Zapf; Christina Krüger; Shahpour Sharifzadeh; Benjamin Schomburg; Frank Leypoldt; Jan Rupp; Siegfried Görg; Ralf Junker; Klaus-Peter Wandinger
Journal:  Clin Microbiol Infect       Date:  2021-09-20       Impact factor: 13.310

3.  Effect of early application of social distancing interventions on COVID-19 mortality over the first pandemic wave: An analysis of longitudinal data from 37 countries.

Authors:  Daniele Piovani; Maria Nefeli Christodoulou; Andreas Hadjidemetriou; Katerina Pantavou; Paraskevi Zaza; Pantelis G Bagos; Stefanos Bonovas; Georgios K Nikolopoulos
Journal:  J Infect       Date:  2020-12-01       Impact factor: 6.072

4.  Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic.

Authors:  Marc Baay; Bruno Lina; Arnaud Fontanet; Arnaud Marchant; Melanie Saville; Philippe Sabot; Joris Vandeputte; Pieter Neels
Journal:  Biologicals       Date:  2020-11-19       Impact factor: 1.856

5.  Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study.

Authors:  Fabrice Carrat; Mathilde Touvier; Gianluca Severi; Laurence Meyer; Florence Jusot; Nathanael Lapidus; Delphine Rahib; Nathalie Lydié; Marie-Aline Charles; Pierre-Yves Ancel; Alexandra Rouquette; Xavier de Lamballerie; Marie Zins; Nathalie Bajos
Journal:  BMC Infect Dis       Date:  2021-02-10       Impact factor: 3.090

6.  Lockdown impact on age-specific contact patterns and behaviours, France, April 2020.

Authors:  Paolo Bosetti; Bich-Tram Huynh; Armiya Youssouf Abdou; Marie Sanchez; Catherine Eisenhauer; Noémie Courtejoie; Jérôme Accardo; Henrik Salje; Didier Guillemot; Mathieu Moslonka-Lefebvre; Pierre-Yves Boëlle; Guillaume Béraud; Simon Cauchemez; Lulla Opatowski
Journal:  Euro Surveill       Date:  2021-12

7.  Willingness of Middle Eastern public to receive COVID-19 vaccines.

Authors:  Rana Abu-Farha; Tareq Mukattash; Rania Itani; Samar Karout; Hani M J Khojah; Asia Abed Al-Mahmood; Karem H Alzoubi
Journal:  Saudi Pharm J       Date:  2021-05-31       Impact factor: 4.330

8.  A multi-method approach to modeling COVID-19 disease dynamics in the United States.

Authors:  Amir Mokhtari; Cameron Mineo; Jeffrey Kriseman; Pedro Kremer; Lauren Neal; John Larson
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

9.  "Anti-COVID-19" Medications, Supplements, and Mental Health Status in Indonesian Mothers with School-Age Children.

Authors:  Annette d'Arqom; Brihastami Sawitri; Zamal Nasution; Riko Lazuardi
Journal:  Int J Womens Health       Date:  2021-07-13

10.  Early assessment of the impact of mitigation measures to control COVID-19 in 22 French metropolitan areas, October to November 2020.

Authors:  Guillaume Spaccaferri; Sophie Larrieu; Jérôme Pouey; Clémentine Calba; Thomas Benet; Cécile Sommen; Daniel Lévy-Bruhl; Sabira Smaili; Didier Che; Laurent Filleul; Céline Caserio-Schönemann; Fatima Ait-El-Belghiti; Sylvie Haeghebaert; Jean-Claude Desenclos; Laëtitia Huiart; Anne Laporte; Patrick Rolland
Journal:  Euro Surveill       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.